Jun 16, 2026 06:47AM
May 19, 2026 06:49AM
May 14, 2026 07:11AM
May 11, 2026 07:01AM
Apr 10, 2026 06:46AM
Apr 9, 2026 07:03AM
Feb 4, 2026 07:09AM H.C. Wainwright Reiterates Buy Rating on Invivyd Inc. (IVVD)
Jan 23, 2026 06:49AM
Jan 22, 2026 07:01AM
Jan 21, 2026 04:16AM
Jan 8, 2026 07:08AM
Dec 23, 2025 07:05AM
Dec 22, 2025 06:00AM
Nov 25, 2025 07:06AM D. Boral Capital Downgrades Invivyd Inc. (IVVD) to Hold
Nov 24, 2025 07:01AM
Nov 6, 2025 08:16AM
Nov 3, 2025 06:46AM
Oct 6, 2025 07:01AM
Oct 6, 2025 06:16AM
Oct 2, 2025 04:15PM
Sep 16, 2025 06:57AM H.C. Wainwright Reiterates Buy Rating on Invivyd Inc. (IVVD)
Aug 19, 2025 06:42AM
Aug 18, 2025 04:33PM
Aug 15, 2025 06:56AM
Aug 14, 2025 04:47PM
Jul 23, 2025 07:03AM
Jul 21, 2025 07:07AM
Jul 2, 2025 07:01AM Invivyd (IVVD) and Leading Researchers Form SPEAR Study Group to Assess the Effects of Monoclonal Antibody Therapy for Long COVID and COVID-19 Post-Vaccination Syndrome
Jun 27, 2025 06:53AM
Jun 26, 2025 07:01AM
May 29, 2025 06:52AM
May 23, 2025 07:02AM
May 15, 2025 04:36PM
May 14, 2025 07:05AM
May 12, 2025 07:01AM Invivyd (IVVD) Announces New Pipeline Discovery Program Focused on Monoclonal Antibody Treatment for Measles
Apr 21, 2025 07:01AM
Mar 26, 2025 04:17PM
Mar 5, 2025 07:05AM
Feb 24, 2025 07:06AM
Feb 4, 2025 06:42AM
Feb 3, 2025 07:02AM
Jan 27, 2025 07:01AM Invivyd (IVVD) Provides Another Positive SARS-CoV-2 Variant Data Analysis to Satisfy U.S. FDA’s Gating Request
Jan 10, 2025 07:08AM
Nov 14, 2024 04:26PM
Oct 30, 2024 07:15AM
Oct 1, 2024 07:08AM
Sep 23, 2024 07:08AM
Sep 4, 2024 07:03AM
Sep 3, 2024 07:01AM Invivyd (IVVD) Announces Continued Neutralizing Activity of PEMGARDA Against Dominant SARS-CoV-2 Variants KP.3.1.1 and LB.1
Sep 3, 2024 06:48AM

416,808 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All